Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement.
Saldi S, Perriello VM, Falini L, Ruggeri L, Fulcheri C, Ciardelli S, Innocente A, Ballanti S, Baffa N, Flenghi L, Pierini A, Aristei C, Falini B. Saldi S, et al. Among authors: falini l. Front Immunol. 2022 Jul 14;13:934700. doi: 10.3389/fimmu.2022.934700. eCollection 2022. Front Immunol. 2022. PMID: 35911683 Free PMC article.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Venanzi A, Marra A, Schiavoni G, Milner SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L, Pucciarini A, Falini L, Sciabolacci S, Martelli MP, Sportoletti P, Ascani S, Falini B, Tiacci E. Venanzi A, et al. Among authors: falini l. Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10. Blood Cancer Discov. 2021. PMID: 34164626 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34233286
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.
Falini L, Venanzi A, Tini V, Innocente A, Ballanti S, Saldi S, Sivolella S, Pierini A, Aristei C, Tiacci E, Perriello VM, Falini B. Falini L, et al. Haematologica. 2023 Jan 1;108(1):290-294. doi: 10.3324/haematol.2022.281351. Haematologica. 2023. PMID: 35899391 Free PMC article. No abstract available.
Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax.
Perriello VM, Falini L, Ruggeri L, Sorcini D, Ballanti S, Flenghi L, Baffa N, Covarelli P, Sportoletti P, Pierini A, Falini B. Perriello VM, et al. Among authors: falini l. EJHaem. 2023 Apr 10;4(2):559-562. doi: 10.1002/jha2.655. eCollection 2023 May. EJHaem. 2023. PMID: 37206291 Free PMC article. No abstract available.
12 results